Global Respiratory Syncytial Virus Diagnostic Testing Supply, Demand and Key Producers, 2023-2029
The global Respiratory Syncytial Virus Diagnostic Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.
This report studies the global Respiratory Syncytial Virus Diagnostic Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Respiratory Syncytial Virus Diagnostic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Respiratory Syncytial Virus Diagnostic Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Respiratory Syncytial Virus Diagnostic Testing total market, 2018-2029, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Respiratory Syncytial Virus Diagnostic Testing total market, key domestic companies and share, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing revenue by player and market share 2018-2023, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Respiratory Syncytial Virus Diagnostic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc. and Cepheid (Danaher Corporation), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Respiratory Syncytial Virus Diagnostic Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Respiratory Syncytial Virus Diagnostic Testing Market, By Region:
1. How big is the global Respiratory Syncytial Virus Diagnostic Testing market?
2. What is the demand of the global Respiratory Syncytial Virus Diagnostic Testing market?
3. What is the year over year growth of the global Respiratory Syncytial Virus Diagnostic Testing market?
4. What is the total value of the global Respiratory Syncytial Virus Diagnostic Testing market?
5. Who are the major players in the global Respiratory Syncytial Virus Diagnostic Testing market?
6. What are the growth factors driving the market demand?
Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.
This report studies the global Respiratory Syncytial Virus Diagnostic Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Respiratory Syncytial Virus Diagnostic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Respiratory Syncytial Virus Diagnostic Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Respiratory Syncytial Virus Diagnostic Testing total market, 2018-2029, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Respiratory Syncytial Virus Diagnostic Testing total market, key domestic companies and share, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing revenue by player and market share 2018-2023, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing total market by Type, CAGR, 2018-2029, (USD Million)
Global Respiratory Syncytial Virus Diagnostic Testing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Respiratory Syncytial Virus Diagnostic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc. and Cepheid (Danaher Corporation), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Respiratory Syncytial Virus Diagnostic Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Respiratory Syncytial Virus Diagnostic Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antigen Detection Test
- Molecular Diagnostic Test
- Direct Fluorescent Antibody Test
- Diagnostic Imaging
- Others
- Hospitals
- Diagnostic Laboratories
- Others
- F. Hoffmann-La Roche AG
- Abbott
- Thermo Fisher Scientific
- BD (Becton, Dickinson and Company)
- QuidelOrtho Corporation
- Hologic, Inc.
- Luminex Corporation
- Agilent Technologies, Inc.
- Cepheid (Danaher Corporation)
- DiaSorin S.p.A.
1. How big is the global Respiratory Syncytial Virus Diagnostic Testing market?
2. What is the demand of the global Respiratory Syncytial Virus Diagnostic Testing market?
3. What is the year over year growth of the global Respiratory Syncytial Virus Diagnostic Testing market?
4. What is the total value of the global Respiratory Syncytial Virus Diagnostic Testing market?
5. Who are the major players in the global Respiratory Syncytial Virus Diagnostic Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Respiratory Syncytial Virus Diagnostic Testing Introduction
1.2 World Respiratory Syncytial Virus Diagnostic Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Respiratory Syncytial Virus Diagnostic Testing Total Market by Region (by Headquarter Location)
1.3.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.3 China Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.4 Europe Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.5 Japan Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.6 South Korea Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.7 ASEAN Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.8 India Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Respiratory Syncytial Virus Diagnostic Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Respiratory Syncytial Virus Diagnostic Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.2 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value by Region
2.2.1 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value by Region (2018-2023)
2.2.2 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.4 China Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.5 Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.6 Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.7 South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.8 ASEAN Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.9 India Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
3 WORLD RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTIC TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Respiratory Syncytial Virus Diagnostic Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Respiratory Syncytial Virus Diagnostic Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Respiratory Syncytial Virus Diagnostic Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Respiratory Syncytial Virus Diagnostic Testing in 2022
3.3 Respiratory Syncytial Virus Diagnostic Testing Company Evaluation Quadrant
3.4 Respiratory Syncytial Virus Diagnostic Testing Market: Overall Company Footprint Analysis
3.4.1 Respiratory Syncytial Virus Diagnostic Testing Market: Region Footprint
3.4.2 Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Type Footprint
3.4.3 Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Comparison
4.2.1 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Respiratory Syncytial Virus Diagnostic Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023)
4.4 China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Respiratory Syncytial Virus Diagnostic Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023)
4.5 Rest of World Based Respiratory Syncytial Virus Diagnostic Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antigen Detection Test
5.2.2 Molecular Diagnostic Test
5.2.3 Direct Fluorescent Antibody Test
5.2.4 Diagnostic Imaging
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2018-2023)
5.3.2 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2024-2029)
5.3.3 World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2018-2023)
6.3.2 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2024-2029)
6.3.3 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche AG
7.1.1 F. Hoffmann-La Roche AG Details
7.1.2 F. Hoffmann-La Roche AG Major Business
7.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.1.4 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 F. Hoffmann-La Roche AG Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.2.4 Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.3.4 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 BD (Becton, Dickinson and Company)
7.4.1 BD (Becton, Dickinson and Company) Details
7.4.2 BD (Becton, Dickinson and Company) Major Business
7.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.4.4 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 BD (Becton, Dickinson and Company) Recent Developments/Updates
7.4.6 BD (Becton, Dickinson and Company) Competitive Strengths & Weaknesses
7.5 QuidelOrtho Corporation
7.5.1 QuidelOrtho Corporation Details
7.5.2 QuidelOrtho Corporation Major Business
7.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.5.4 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 QuidelOrtho Corporation Recent Developments/Updates
7.5.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
7.6 Hologic, Inc.
7.6.1 Hologic, Inc. Details
7.6.2 Hologic, Inc. Major Business
7.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.6.4 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Hologic, Inc. Recent Developments/Updates
7.6.6 Hologic, Inc. Competitive Strengths & Weaknesses
7.7 Luminex Corporation
7.7.1 Luminex Corporation Details
7.7.2 Luminex Corporation Major Business
7.7.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.7.4 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Luminex Corporation Recent Developments/Updates
7.7.6 Luminex Corporation Competitive Strengths & Weaknesses
7.8 Agilent Technologies, Inc.
7.8.1 Agilent Technologies, Inc. Details
7.8.2 Agilent Technologies, Inc. Major Business
7.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.8.4 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Agilent Technologies, Inc. Recent Developments/Updates
7.8.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
7.9 Cepheid (Danaher Corporation)
7.9.1 Cepheid (Danaher Corporation) Details
7.9.2 Cepheid (Danaher Corporation) Major Business
7.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.9.4 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Cepheid (Danaher Corporation) Recent Developments/Updates
7.9.6 Cepheid (Danaher Corporation) Competitive Strengths & Weaknesses
7.10 DiaSorin S.p.A.
7.10.1 DiaSorin S.p.A. Details
7.10.2 DiaSorin S.p.A. Major Business
7.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.10.4 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 DiaSorin S.p.A. Recent Developments/Updates
7.10.6 DiaSorin S.p.A. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Respiratory Syncytial Virus Diagnostic Testing Industry Chain
8.2 Respiratory Syncytial Virus Diagnostic Testing Upstream Analysis
8.3 Respiratory Syncytial Virus Diagnostic Testing Midstream Analysis
8.4 Respiratory Syncytial Virus Diagnostic Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Respiratory Syncytial Virus Diagnostic Testing Introduction
1.2 World Respiratory Syncytial Virus Diagnostic Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Respiratory Syncytial Virus Diagnostic Testing Total Market by Region (by Headquarter Location)
1.3.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.3 China Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.4 Europe Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.5 Japan Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.6 South Korea Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.7 ASEAN Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.3.8 India Respiratory Syncytial Virus Diagnostic Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Respiratory Syncytial Virus Diagnostic Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Respiratory Syncytial Virus Diagnostic Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.2 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value by Region
2.2.1 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value by Region (2018-2023)
2.2.2 World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.4 China Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.5 Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.6 Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.7 South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.8 ASEAN Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
2.9 India Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029)
3 WORLD RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTIC TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Respiratory Syncytial Virus Diagnostic Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Respiratory Syncytial Virus Diagnostic Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Respiratory Syncytial Virus Diagnostic Testing in 2022
3.2.3 Global Concentration Ratios (CR8) for Respiratory Syncytial Virus Diagnostic Testing in 2022
3.3 Respiratory Syncytial Virus Diagnostic Testing Company Evaluation Quadrant
3.4 Respiratory Syncytial Virus Diagnostic Testing Market: Overall Company Footprint Analysis
3.4.1 Respiratory Syncytial Virus Diagnostic Testing Market: Region Footprint
3.4.2 Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Type Footprint
3.4.3 Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Comparison
4.2.1 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Respiratory Syncytial Virus Diagnostic Testing Companies and Market Share, 2018-2023
4.3.1 United States Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023)
4.4 China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue and Market Share, 2018-2023
4.4.1 China Based Respiratory Syncytial Virus Diagnostic Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023)
4.5 Rest of World Based Respiratory Syncytial Virus Diagnostic Testing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antigen Detection Test
5.2.2 Molecular Diagnostic Test
5.2.3 Direct Fluorescent Antibody Test
5.2.4 Diagnostic Imaging
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2018-2023)
5.3.2 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2024-2029)
5.3.3 World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2018-2023)
6.3.2 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2024-2029)
6.3.3 World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche AG
7.1.1 F. Hoffmann-La Roche AG Details
7.1.2 F. Hoffmann-La Roche AG Major Business
7.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.1.4 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 F. Hoffmann-La Roche AG Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.2.4 Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.3.4 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 BD (Becton, Dickinson and Company)
7.4.1 BD (Becton, Dickinson and Company) Details
7.4.2 BD (Becton, Dickinson and Company) Major Business
7.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.4.4 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 BD (Becton, Dickinson and Company) Recent Developments/Updates
7.4.6 BD (Becton, Dickinson and Company) Competitive Strengths & Weaknesses
7.5 QuidelOrtho Corporation
7.5.1 QuidelOrtho Corporation Details
7.5.2 QuidelOrtho Corporation Major Business
7.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.5.4 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 QuidelOrtho Corporation Recent Developments/Updates
7.5.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
7.6 Hologic, Inc.
7.6.1 Hologic, Inc. Details
7.6.2 Hologic, Inc. Major Business
7.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.6.4 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Hologic, Inc. Recent Developments/Updates
7.6.6 Hologic, Inc. Competitive Strengths & Weaknesses
7.7 Luminex Corporation
7.7.1 Luminex Corporation Details
7.7.2 Luminex Corporation Major Business
7.7.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.7.4 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Luminex Corporation Recent Developments/Updates
7.7.6 Luminex Corporation Competitive Strengths & Weaknesses
7.8 Agilent Technologies, Inc.
7.8.1 Agilent Technologies, Inc. Details
7.8.2 Agilent Technologies, Inc. Major Business
7.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.8.4 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Agilent Technologies, Inc. Recent Developments/Updates
7.8.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
7.9 Cepheid (Danaher Corporation)
7.9.1 Cepheid (Danaher Corporation) Details
7.9.2 Cepheid (Danaher Corporation) Major Business
7.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.9.4 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Cepheid (Danaher Corporation) Recent Developments/Updates
7.9.6 Cepheid (Danaher Corporation) Competitive Strengths & Weaknesses
7.10 DiaSorin S.p.A.
7.10.1 DiaSorin S.p.A. Details
7.10.2 DiaSorin S.p.A. Major Business
7.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Product and Services
7.10.4 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 DiaSorin S.p.A. Recent Developments/Updates
7.10.6 DiaSorin S.p.A. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Respiratory Syncytial Virus Diagnostic Testing Industry Chain
8.2 Respiratory Syncytial Virus Diagnostic Testing Upstream Analysis
8.3 Respiratory Syncytial Virus Diagnostic Testing Midstream Analysis
8.4 Respiratory Syncytial Virus Diagnostic Testing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Respiratory Syncytial Virus Diagnostic Testing Players in 2022
Table 12. World Respiratory Syncytial Virus Diagnostic Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Respiratory Syncytial Virus Diagnostic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Respiratory Syncytial Virus Diagnostic Testing Player
Table 15. Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Type Footprint
Table 16. Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Application Footprint
Table 17. Respiratory Syncytial Virus Diagnostic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Respiratory Syncytial Virus Diagnostic Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Respiratory Syncytial Virus Diagnostic Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share (2018-2023)
Table 23. China Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share (2018-2023)
Table 29. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. F. Hoffmann-La Roche AG Basic Information, Area Served and Competitors
Table 36. F. Hoffmann-La Roche AG Major Business
Table 37. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 38. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. F. Hoffmann-La Roche AG Recent Developments/Updates
Table 40. F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
Table 41. Abbott Basic Information, Area Served and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 44. Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 50. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. BD (Becton, Dickinson and Company) Basic Information, Area Served and Competitors
Table 54. BD (Becton, Dickinson and Company) Major Business
Table 55. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 56. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. BD (Becton, Dickinson and Company) Recent Developments/Updates
Table 58. BD (Becton, Dickinson and Company) Competitive Strengths & Weaknesses
Table 59. QuidelOrtho Corporation Basic Information, Area Served and Competitors
Table 60. QuidelOrtho Corporation Major Business
Table 61. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 62. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. QuidelOrtho Corporation Recent Developments/Updates
Table 64. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 65. Hologic, Inc. Basic Information, Area Served and Competitors
Table 66. Hologic, Inc. Major Business
Table 67. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 68. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Hologic, Inc. Recent Developments/Updates
Table 70. Hologic, Inc. Competitive Strengths & Weaknesses
Table 71. Luminex Corporation Basic Information, Area Served and Competitors
Table 72. Luminex Corporation Major Business
Table 73. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 74. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Luminex Corporation Recent Developments/Updates
Table 76. Luminex Corporation Competitive Strengths & Weaknesses
Table 77. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
Table 78. Agilent Technologies, Inc. Major Business
Table 79. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 80. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Agilent Technologies, Inc. Recent Developments/Updates
Table 82. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 83. Cepheid (Danaher Corporation) Basic Information, Area Served and Competitors
Table 84. Cepheid (Danaher Corporation) Major Business
Table 85. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 86. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Cepheid (Danaher Corporation) Recent Developments/Updates
Table 88. DiaSorin S.p.A. Basic Information, Area Served and Competitors
Table 89. DiaSorin S.p.A. Major Business
Table 90. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 91. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Respiratory Syncytial Virus Diagnostic Testing Upstream (Raw Materials)
Table 93. Respiratory Syncytial Virus Diagnostic Testing Typical Customers
Table 1. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Respiratory Syncytial Virus Diagnostic Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Respiratory Syncytial Virus Diagnostic Testing Players in 2022
Table 12. World Respiratory Syncytial Virus Diagnostic Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Respiratory Syncytial Virus Diagnostic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Respiratory Syncytial Virus Diagnostic Testing Player
Table 15. Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Type Footprint
Table 16. Respiratory Syncytial Virus Diagnostic Testing Market: Company Product Application Footprint
Table 17. Respiratory Syncytial Virus Diagnostic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Respiratory Syncytial Virus Diagnostic Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Respiratory Syncytial Virus Diagnostic Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share (2018-2023)
Table 23. China Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Respiratory Syncytial Virus Diagnostic Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share (2018-2023)
Table 29. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. F. Hoffmann-La Roche AG Basic Information, Area Served and Competitors
Table 36. F. Hoffmann-La Roche AG Major Business
Table 37. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 38. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. F. Hoffmann-La Roche AG Recent Developments/Updates
Table 40. F. Hoffmann-La Roche AG Competitive Strengths & Weaknesses
Table 41. Abbott Basic Information, Area Served and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 44. Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 50. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. BD (Becton, Dickinson and Company) Basic Information, Area Served and Competitors
Table 54. BD (Becton, Dickinson and Company) Major Business
Table 55. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 56. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. BD (Becton, Dickinson and Company) Recent Developments/Updates
Table 58. BD (Becton, Dickinson and Company) Competitive Strengths & Weaknesses
Table 59. QuidelOrtho Corporation Basic Information, Area Served and Competitors
Table 60. QuidelOrtho Corporation Major Business
Table 61. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 62. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. QuidelOrtho Corporation Recent Developments/Updates
Table 64. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 65. Hologic, Inc. Basic Information, Area Served and Competitors
Table 66. Hologic, Inc. Major Business
Table 67. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 68. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Hologic, Inc. Recent Developments/Updates
Table 70. Hologic, Inc. Competitive Strengths & Weaknesses
Table 71. Luminex Corporation Basic Information, Area Served and Competitors
Table 72. Luminex Corporation Major Business
Table 73. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 74. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Luminex Corporation Recent Developments/Updates
Table 76. Luminex Corporation Competitive Strengths & Weaknesses
Table 77. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
Table 78. Agilent Technologies, Inc. Major Business
Table 79. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 80. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Agilent Technologies, Inc. Recent Developments/Updates
Table 82. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 83. Cepheid (Danaher Corporation) Basic Information, Area Served and Competitors
Table 84. Cepheid (Danaher Corporation) Major Business
Table 85. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 86. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Cepheid (Danaher Corporation) Recent Developments/Updates
Table 88. DiaSorin S.p.A. Basic Information, Area Served and Competitors
Table 89. DiaSorin S.p.A. Major Business
Table 90. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Product and Services
Table 91. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Respiratory Syncytial Virus Diagnostic Testing Upstream (Raw Materials)
Table 93. Respiratory Syncytial Virus Diagnostic Testing Typical Customers
LIST OF FIGURES
Figure 1. Respiratory Syncytial Virus Diagnostic Testing Picture
Figure 2. World Respiratory Syncytial Virus Diagnostic Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Respiratory Syncytial Virus Diagnostic Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 13. Respiratory Syncytial Virus Diagnostic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Respiratory Syncytial Virus Diagnostic Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Respiratory Syncytial Virus Diagnostic Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Respiratory Syncytial Virus Diagnostic Testing Markets in 2022
Figure 27. United States VS China: Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Type in 2022
Figure 31. Antigen Detection Test
Figure 32. Molecular Diagnostic Test
Figure 33. Direct Fluorescent Antibody Test
Figure 34. Diagnostic Imaging
Figure 35. Others
Figure 36. World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Type (2018-2029)
Figure 37. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Application in 2022
Figure 39. Hospitals
Figure 40. Diagnostic Laboratories
Figure 41. Others
Figure 42. Respiratory Syncytial Virus Diagnostic Testing Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Respiratory Syncytial Virus Diagnostic Testing Picture
Figure 2. World Respiratory Syncytial Virus Diagnostic Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Respiratory Syncytial Virus Diagnostic Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Respiratory Syncytial Virus Diagnostic Testing Revenue (2018-2029) & (USD Million)
Figure 13. Respiratory Syncytial Virus Diagnostic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Respiratory Syncytial Virus Diagnostic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Respiratory Syncytial Virus Diagnostic Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Respiratory Syncytial Virus Diagnostic Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Respiratory Syncytial Virus Diagnostic Testing Markets in 2022
Figure 27. United States VS China: Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Respiratory Syncytial Virus Diagnostic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Type in 2022
Figure 31. Antigen Detection Test
Figure 32. Molecular Diagnostic Test
Figure 33. Direct Fluorescent Antibody Test
Figure 34. Diagnostic Imaging
Figure 35. Others
Figure 36. World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Type (2018-2029)
Figure 37. World Respiratory Syncytial Virus Diagnostic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Respiratory Syncytial Virus Diagnostic Testing Market Size Market Share by Application in 2022
Figure 39. Hospitals
Figure 40. Diagnostic Laboratories
Figure 41. Others
Figure 42. Respiratory Syncytial Virus Diagnostic Testing Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
